.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Deloitte
Johnson and Johnson
QuintilesIMS
UBS
Fuji
Healthtrust
Novartis
Federal Trade Commission
Colorcon

Generated: July 27, 2017

DrugPatentWatch Database Preview

AMINOSYN 3.5% Drug Profile

« Back to Dashboard

Which patents cover Aminosyn 3.5%, and when can generic versions of Aminosyn 3.5% launch?

Aminosyn 3.5% is a drug marketed by Icu Medical Inc and Abbott and is included in five NDAs.

The generic ingredient in AMINOSYN 3.5% is amino acids; dextrose. There are three hundred and thirty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; dextrose profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc
AMINOSYN 3.5%
amino acids
INJECTABLE;INJECTION017789-004Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN 3.5% M IN PLASTIC CONTAINER
amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
INJECTABLE;INJECTION018875-002Aug 8, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Icu Medical Inc
AMINOSYN 3.5% M
amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
INJECTABLE;INJECTION017789-003Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION019118-001Oct 11, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN 3.5% IN PLASTIC CONTAINER
amino acids
INJECTABLE;INJECTION018804-001May 15, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Argus Health
Teva
Harvard Business School
Novartis
Cipla
Merck
Mallinckrodt
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot